Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kinepict Health is a private Hungarian medical imaging software company focused on improving angiography and image-guided vascular interventions. Its core technology, Digital Variance Angiography, is a patented image-processing approach that enhances angiographic visualization while helping reduce iodinated contrast-media use and X-ray dose. The company commercializes this technology through the Kinepict Medical Imaging Tool, a CE-marked and FDA-cleared software platform used in interventional radiology and vascular surgery workflows. Kinepict positions its products as safer and more informative alternatives to conventional angiographic image processing, particularly for visualizing small vessels and stenotic lesions. The company appears to be an active healthtech business rather than a therapeutics developer, with its value centered on imaging software, clinical validation, and commercialization of procedural guidance tools.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kinepict Health.